Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rekombinanter VWF Antikörper (AA 1815-1939)

VWF Reaktivität: Human WB, IP, IF, IHC (p) Wirt: Kaninchen Monoclonal VWF-1859R unconjugated Recombinant Antibody
Produktnummer ABIN5646932
  • Target Alle VWF Antikörper anzeigen
    VWF (Von Willebrand Factor (VWF))
    Antikörpertyp
    Recombinant Antibody
    Bindungsspezifität
    • 30
    • 16
    • 11
    • 10
    • 7
    • 5
    • 5
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1815-1939
    Reaktivität
    • 146
    • 37
    • 26
    • 5
    • 4
    • 3
    Human
    Wirt
    • 85
    • 78
    • 12
    • 5
    Kaninchen
    Klonalität
    • 91
    • 86
    • 1
    Monoklonal
    Konjugat
    • 90
    • 20
    • 15
    • 6
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser VWF Antikörper ist unkonjugiert
    Applikation
    • 101
    • 101
    • 68
    • 54
    • 47
    • 43
    • 24
    • 18
    • 16
    • 15
    • 14
    • 9
    • 9
    • 8
    • 8
    • 5
    • 5
    • 5
    • 4
    • 3
    • 1
    Western Blotting (WB), Immunoprecipitation (IP), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
    Aufreinigung
    Purified
    Reinheit
    Protein A affinity chromatography
    Immunogen
    Amino acids 1815-1939 from the human protein were used as the immunogen for this recombinant vWF antibody.
    Klon
    VWF-1859R
    Isotyp
    IgG kappa
    Top Product
    Discover our top product VWF Primärantikörper
  • Applikationshinweise
    The optimal dilution of the recombinant vWF antibody for each application should be determined by the researcher.

    1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.\. Western blot: 1-2 μg/mL,Immunoprecipitation: 1-2 μg/500 μg lysate,Immunofluorescence: 1-2 μg/mL,Immunohistochemistry (FFPE): 1-2 μg/mL for 30 minutes at RT

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Konzentration
    0.2 mg/mL
    Buffer
    0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced) and 0.05 % sodium azide
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    Store the recombinant vWF antibody at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide).
  • Target
    VWF (Von Willebrand Factor (VWF))
    Andere Bezeichnung
    von Willebrand Factor / vWF (VWF Produkte)
    Synonyme
    VWF antikoerper, si:ch1073-474e24.1 antikoerper, F8VWF antikoerper, VWD antikoerper, 6820430P06Rik antikoerper, AI551257 antikoerper, B130011O06Rik antikoerper, C630030D09 antikoerper, von Willebrand factor antikoerper, Von Willebrand factor antikoerper, VWF antikoerper, vwf antikoerper, Vwf antikoerper
    Hintergrund
    Von Willebrand Factor (vWF) is a multimeric glycoprotein that is found in endothelial cells, plasma and platelets. It acts as a carrier protein for Factor VIII and promotes platelet adhesion and aggregation. vWF undergoes a variety of posttranslational modifications that influence the affinity and availability for Factor VIII, including cleavage of the propeptide and formation of N-terminal disulfide bonds. This antibody helps to establish the endothelial nature of some lesions of disputed histogenesis, e.g. Kaposi's sarcoma and cardiac myxoma. It is widely used for differentiating vascular lesions from those of other tissue differentiation within a panel of other vascular markers although not all tumors of endothelial differentiation contain this antigen.
Sie sind hier:
Kundenservice